Pfizer and Hippolia Foundation Form Partnership

Pfizer Animal Health and The Hippolia Foundation have announced the formation of a strategic partnership to advance equine health through research and educational programs.

The Hippolia Foundation—a network of leading French equine institutions together with international partners—will collaborate with Pfizer to accelerate advancement in innovation on the diagnosis, treatment and prevention of equine disease. The Hippolia partner organizations and Pfizer are initially investing more than $5 million over three years.

"This is an excellent example of a public/private initiative to advance our scientific knowledge and improve animal health and welfare," said Pierre Lekeux, president of The Hippolia Foundation.

The two principal areas of collaboration to be developed between Pfizer and The Hippolia Foundation will focus on respiratory disorders and on infectious diseases.

"This is a particularly synergistic partnership," said Alejandro Bernal, area president of Pfizer Animal Health (Europe, Africa, and Middle East). "Together, The Hippolia Foundation and Pfizer have created a partnership based on what is today the largest equine research network worldwide. Both parties will benefit from the combined expertise and resources in the interests of accelerating pioneering equine research."

Pfizer Animal Health has a broad and leading portfolio of parasiticides, pharmaceuticals, and core and specialty vaccines.

In November 2011, the company opened a new global equine research center at its worldwide veterinary medicine research and development headquarters in greater Kalamazoo, Mich. Pfizer Animal Health is dedicated to providing comprehensive solutions for equine health, including an integrated offer of vaccines, therapeutics, diagnostics, practice management, and services.

Founded in 2011 and located in Normandy at the center of one of Europe's most recognized regions for competition horses, The Hippolia Foundation supports and promotes the development of research programs, training, and services at an international level, particularly on issues of health, welfare, and performance in horses. 

The Normandy site has established a reputation as a world-class facility undertaking leading-edge research on racehorses (Thoroughbred and Standardbred) but also on sport horses. The Hippolia Foundation also has existing partnerships with hospitals, and it is expected that its research could possibly have comparative translational aspects that would benefit human health as well as equine health. 

Stay on top of the most recent Horse Health news with FREE weekly newsletters from Learn More